KRT5 and adenocarcinoma: The adenocarcinoma subtype of lung cancer also expressed CK 5/6 but to an appreciably lesser extent than lung SCC; 22.2% of primary adenocarcinomas and 15.4% of metastatic adenocarcinomas have been found to express CK5/640.